工商時報生華科與美商Banner Health 簽新冠MOU
作者 彭暄貽
<p>生華科(6492)宣布新藥CK2抑制劑Silmitasertib (CX-4945)在抗新冠肺炎的臨床進展有重 […]</p> <p>The post <a rel="nofollow" href="https://ctee.com.tw/news/biotech/314249.html">生...
<p>生華科(6492)宣布新藥CK2抑制劑Silmitasertib (CX-4945)在抗新冠肺炎的臨床進展有重 […]</p> <p>The post <a rel="nofollow" href="https://ctee.com.tw/news/biotech/314249.html">生...